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Background: Treadmill training is well recognized as an effective therapy to improve exercise performance and community-based walking ability. 
This is the first report to study the effect of treadmill and ergometer exercise on exercise-tolerance as well as cardio-renal function in patients with 
peripheral arterial disease (PAD).
Methods: Patients (15m, 3f, mean age 74yrs) diagnosed as PAD with claudication using angiography, multi-detector computed tomography or 
vascular echo were randomly enrolled to either the treadmill or the ergometer exercise group. They carried out exercise once a week for 30 minutes 
for 12 weeks with education of life style modification. We determined the several index involving: 1) initial claudication distance (ICD), maximum 
walking distance(MWD) 2) walking impairment questionnaire (WIQ) score 3) intima-media thickness (IMT) of carotid artery 4) laboratory data 
contained estimated glomerular filtration rate (eGFR) and brain natriuretic peptide(BNP).
Results: As shown in the Table, ICD improve 475±339m to 717±316m, MWD improve 753±299m to 889±223m, BNP improve 76.2±67.2 pg/
ml to 49.3±43.3 pg/ml, eGFR improve 58.5±27.0 ml/min to 62.4±27.8 ml/min, max IMT improve 1.93±0.50mm to 1.77±0.43mm in all patients 
analysis. There is no significant difference of changes in these parameters between two groups.
Conclusions: This study indicated low frequent treadmill and ergometer exercise equally can improve both exercise-tolerance and cardio-renal 
function in PAD patients.
Changes in outcomes for PAD patients after 12 week treadmill and ergometer exercise
Outcomes
Baseline
Tredmill group
12 week
Tredmill group
Baseline
Ergometer group
12 week
Ergometer group
Baseline
All patients
12 week
All patients
Tredmill group vs 
Ergometer group
Patients 5M, 3F 73.8±7.9yr 10M, 76.5±7.4yr 15M, 3F 75.3±6.3yr
ICD 471±272m 844±197m 478±308m 660±341m 475±339m 717±316m(P=0.0048) no significant difference
MWD 800±250m 944±98m 725±260m 820±252m 753±299m 889±233m(P=0.0032) no significant difference
WIQ score 214±86.9 290±62.7 225±60.9 239±63.7 200±73.6 262±68.85(P=0.0179) no significant difference
BNP 59.3±44.8 pg/ml 47.8±52.9 pg/ml 91.2±82.0 pg/ml 50.7±35.9 pg/ml 76.2±67.2 pg/ml 49.3±43.3 pg/ml (P=0.0156) no significant difference
eGFR 58.2±26.1 ml/min 58.7±61.5 ml/min 58.7±26.1 ml/min 63.1±28.1 ml/min 58.5±27.0 ml/min 62.4±27.8 ml/min (P=0.0428) no significant difference
max IMT of carotid artery 1.55±0.37mm 1.71±0.51mm 2.10±0.39mm 1.82±0.36mm 1.93±0.50mm 1.77±0.43mm(P=0.0102) no significant difference
mean IMT of carotid artery 1.27±0.27mm 1.26±0.29mm 1.71±0.54mm 1.44±0.33mm 1.47±0.38mm 1.40±0.34mm(P=0.0053) no significant difference
PAD:Peripheral Arterial Disease, ICD:initial claudication distance, MWD:maximum walking distance, WIQ score:walking impairment questionnaire score, BNP:brain natriuretic peptide, eGFR:estimated glomerular 
filtration rate, IMT:intima-media thickness
